One-year results of simultaneous laser in situ keratomileusis and small-aperture corneal inlay implantation for hyperopic XXXX : Comparison by age.

@entity1 @entity10818 @entity940
PURPOSE: To compare by age the safety, efficacy, and @entity1 satisfaction after simultaneous laser in situ keratomileusis (LASIK) and small-aperture corneal inlay implantation (Kamra) for hyperopic @entity10818 . SETTING: Shinagawa LASIK Center, Tokyo, Japan. DESIGN: Retrospective comparative cohort study. METHODS: Simultaneous LASIK and small-aperture corneal inlay implantation were performed in the nondominant eye of hyperopic presbyopic @entity1 with @entity940 . @entity1 were divided into groups by age as follows: Group 1 (40 to 49  years), Group 2 (50 to 59  years), and Group 3 (60 to 65  years). The uncorrected (UDVA) and corrected (CDVA) distance visual acuities, uncorrected near visual acuity (UNVA), and @entity1 questionnaire results were compared. RESULTS: The study evaluated 277 eyes of 277 @entity1 . All groups achieved a mean UDVA of 20/20, with Group 1, Group 2, and Group 3 gaining 1 line, 2 lines, and 3 lines, respectively. The mean UNVA was J2 with 4 lines gained in Group 1 and J3 with 5 lines gained in Group 2 and Group 3. The mean CDVA and corrected near visual acuity remained the same as at baseline. CONCLUSIONS: Simultaneous LASIK and small-aperture corneal inlay implantation for hyperopic @entity10818 was a safe and effective treatment option. Although the outcomes were comparable between groups, Group 3 had the largest gain in UDVA and UNVA and the highest @entity1 satisfaction, despite having the lowest reduction in dependence on reading glasses. Taking age into account might help achieve optimum postoperative outcomes and improved @entity1 satisfaction. FINANCIAL DISCLOSURE: Dr. Tomita is a consultant to Ziemer Ophthalmic Systems AG, Acufocus, Inc., and Schwind eye-tech-solutions GmbH and Co. KG. Dr. Waring is a consultant to Acufocus, Inc.
